On Tuesday, Cantor Fitzgerald reiterated its confidence in ORIC Pharmaceuticals (NASDAQ:ORIC), maintaining an Overweight stock rating. Trading at $11.49, ORIC has seen analyst targets ranging from ...

On Monday, Cantor Fitzgerald reaffirmed its Overweight rating on Surgery Partners (NASDAQ:SGRY) with a steady price target of $36.00. The stock, which has shown significant momentum with a 20% ...

In a report released yesterday, Troy Jensen from Cantor Fitzgerald reiterated a Buy rating on Proto Labs (PRLB – Research Report), with a price target of $50.00. The company’s shares closed ...

As previously reported last night, Cantor Fitzgerald analyst Colin Canfield initiated coverage of five Government Technology & Space, or “GovTech,” stocks, starting SAIC (SAIC) with a Neutral ...

Cantor Fitzgerald has a convertible bond with Tether, incoming Commerce Secretary Howard Lutnick said at his confirmation hearing, confirming previous reporting by The Wall Street Journal that ...

Cantor Fitzgerald raised the firm’s price target on PTC Therapeutics (PTCT) to $113 from $76 and keeps an Overweight rating on the shares. PTC has several regulatory decisions this year ...

Cantor Fitzgerald lowered the firm’s price target on Cigna (CI) to $350 from $400 and keeps an Overweight rating on the shares. Cantor is confident that Cigna can correct their stop-loss pricing ...

Howard Lutnick, the chairman of Cantor Fitzgerald and nominee for U.S. Commerce Secretary, faced questioning from Senate Democrats regarding the financial firm's investment in Tether, the entity ...

Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) – Cantor Fitzgerald issued their FY2025 earnings per share estimates for shares of Fate Therapeutics in a report issued on Tuesday ...

Brett Knoblauch, Cantor Fitzgerald head of digital asset research, joins 'Power Lunch' to discuss the energy needed to power AI in Stargate deal and the winners from it. Coast Guard Investigates ...

billionaire chairman and CEO of Wall Street firm Cantor Fitzgerald, to run the Commerce Department. The Senate Commerce Committee voted 16-12 with all Democrats except Senator John Fetterman ...

Palantir Technologies Inc. (NASDAQ:PLTR – Free Report) – Equities research analysts at Cantor Fitzgerald issued their FY2025 earnings estimates for Palantir Technologies in a note issued to ...